Intensity Therapeutics, Inc. (INTS)
NASDAQ:INTS
US Market
Holding INTS?
Track your performance easily

Intensity Therapeutics, Inc. (INTS) Income Statement

28 Followers

Intensity Therapeutics, Inc. Income Statement

Last quarter (Q2 2024), Intensity Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q2, Intensity Therapeutics, Inc.'s net income was $-4.97M. See Intensity Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
-
Cost of Revenue
-
Gross Profit
-
Operating Expense
$ 8.32M
Operating Income
$ -8.32M
Net Non Operating Interest Income Expense
$ 19.00K
Other Income Expense
$ -2.24M
Pretax Income
$ -10.54M
Tax Provision
$ -350.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -11.86M
Basic EPS
$ -1.38
Diluted EPS
$ -1.38
Basic Average Shares
$ 8.62M
Diluted Average Shares
$ 8.62M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 8.32M
Net Income From Continuing And Discontinued Operation
$ -10.54M
Normalized Income
$ -10.89M
Interest Expense
-
EBIT
$ -10.23M
EBITDA
$ -10.23M
Currency in USD

Intensity Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis